The clinical research to evaluate the efficacy of landiolol on cardiac function in patients with acute heart failure
Not Applicable
Recruiting
- Conditions
- acute heart failure
- Registration Number
- JPRN-UMIN000004342
- Lead Sponsor
- Department of Medicine and Clinical Science Yamaguchi University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
The exclusion criterion was a systolic blood pressure below 80 mmHg.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1)To evaluate the effect of landiolol on hemodynamics by cardiac catherization 2)To investigate change of indeces of cardiac function by echocardiography
- Secondary Outcome Measures
Name Time Method We recorded any adverse events that occurred during the administration of landiolol, such as hypotension (defined as systolic arterial pressure <60 mmHg), angina, electrocardiographic evidence of ischemia, acute renal failure, dyspnea, or arrhythmia. We also noted the clinical outcome for each patient.